Search Results 61-70 of 28142 for B cell lymphomas
Research. Mayo Clinic doctors and researchers are studying primary mediastinal large B-cell lymphoma (PMBCL) to look for new ways to improve diagnosis and ...
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy · Overview · Participation ...
They begin in lymphocytes called B cells. This cancer affects parts of the nervous system that control thinking, movement and vision, so symptoms often include ...
A complete blood count may be used to count the number of lymphocytes in a blood sample. A high number of B cells, one type of lymphocyte, could mean small ...
A Study Of Copanlisib And Nivolumab In Treating Participants With Recurrent Or Refractory Diffuse Large B-cell Lymphoma Or Primary Mediastinal Large B-cell ...
MALT lymphoma happens when the B lymphocytes grow out of control and form a growth of cancer cells in the mucosa. It can happen after long-term infection or ...
The purpose of this study is to determine how well nivolumab with or without varlilumab works in treating patients with aggressive B-cell lymphomas that have ...
T-cell/histiocyte-rich large B cell lymphoma. Large B-cell lymphoma with ... FDG-nonavid lymphomas: Measurable disease with CT (or MRI) scan with ...
Monoclonal B-cell lymphocytosis (MBL) causes an increased number of a type of lymphocyte, called B lymphocytes, in the blood. ... B-cell lymphoma. This is ...
Giving lenalidomide with R-ICE may be a better treatment for patients with diffuse large B-cell lymphoma. Participation eligibility. Participant eligibility ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.